ProfileGDS4718 / 231334_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 30% 28% 33% 32% 30% 29% 32% 32% 30% 31% 34% 28% 34% 33% 28% 28% 31% 33% 31% 31% 34% 29% 35% 30% 29% 35% 34% 33% 30% 30% 33% 32% 35% 34% 30% 29% 37% 33% 32% 23% 30% 33% 31% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5504330
GSM549102patient 115, normal, homogenized [OPG study]4.4829228
GSM549104patient 119, normal, homogenized [OPG study]4.670633
GSM549108patient 138, normal, homogenized [OPG study]4.6831332
GSM549119patient 077, normal, homogenized [OPG study]4.5422430
GSM549133patient 032, cancer, homogenized [OPG study]4.4203829
GSM549139patient 042, cancer, homogenized [OPG study]4.589432
GSM549099patient 107, normal, homogenized [OPG study]4.6496232
GSM549109patient 139, normal, homogenized [OPG study]4.5834630
GSM549110patient 046, normal, homogenized [OPG study]4.5751931
GSM549114patient 063, normal, homogenized [OPG study]4.6488734
GSM549122patient 082, normal, homogenized [OPG study]4.4492228
GSM549134patient 033, cancer, homogenized [OPG study]4.7077934
GSM549136patient 036, cancer, homogenized [OPG study]4.5913533
GSM549140patient 044, cancer, homogenized [OPG study]4.4168428
GSM549111patient 047, normal, homogenized [OPG study]4.4476328
GSM549113patient 057, normal, homogenized [OPG study]4.5390531
GSM549132patient 031, cancer, homogenized [OPG study]4.6364133
GSM549137patient 038, cancer, homogenized [OPG study]4.5776431
GSM549142patient 047, cancer, homogenized [OPG study]4.6851931
GSM549100patient 110, normal, homogenized [OPG study]4.7220134
GSM549107patient 135, normal, homogenized [OPG study]4.4876729
GSM549115patient 068, normal, homogenized [OPG study]4.6788235
GSM549116patient 072, normal, homogenized [OPG study]4.5283530
GSM549120patient 078, normal, homogenized [OPG study]4.4765129
GSM549131patient 030, cancer, homogenized [OPG study]4.6941635
GSM549118patient 074, normal, homogenized [OPG study]4.696234
GSM549129patient 027, cancer, homogenized [OPG study]4.6657133
GSM549123patient 088, normal, homogenized [OPG study]4.5293430
GSM549124patient 006, cancer, homogenized [OPG study]4.5974230
GSM549126patient 015, cancer, homogenized [OPG study]4.6676533
GSM549128patient 025, cancer, homogenized [OPG study]4.5939632
GSM549103patient 117, normal, homogenized [OPG study]4.8347335
GSM549117patient 073, normal, homogenized [OPG study]4.6994234
GSM549138patient 041, cancer, homogenized [OPG study]4.5369130
GSM549141patient 045, cancer, homogenized [OPG study]4.4370329
GSM549130patient 028, cancer, homogenized [OPG study]4.8658637
GSM549101patient 111, normal, homogenized [OPG study]4.6751433
GSM549105patient 128, normal, homogenized [OPG study]4.6371732
GSM549106patient 134, normal, homogenized [OPG study]4.1934823
GSM549112patient 048, normal, homogenized [OPG study]4.5313330
GSM549125patient 011, cancer, homogenized [OPG study]4.6958833
GSM549127patient 024, cancer, homogenized [OPG study]4.5631131
GSM549135patient 035, cancer, homogenized [OPG study]4.4273828